Posted 21 June, 2023

Azitra Inc IPO completed

IPO completed detected for ticker NYSE:AZTR in a 424B4 filed on 21 June, 2023.

  This is a firm commitment initial public offering of shares of common stock of Azitra, Inc.  

Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Azitra Inc
Health Care/Life Sciences • Biotechnology
Azitra, Inc. is an early-stage clinical biopharmaceutical company, which engages in the development of therapeutic use in dermatology. The firm is involved in using engineered proteins and live bio therapeutic products that can be applied topically to treat diseases of the skin. It also offers a platform which is augmented by artificial intelligence and machine learning technology that analyzes, predicts, and helps screen library of strains for drug like molecules. The company was founded by Azim Munivar and Travis Whitfill on January 2, 2014 and is headquartered in Branford, CT.
Market Cap
View Company Details